NOURESS

Trademark usage description

parenterally-administered pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine-deficien Read More

Classification Information

Class [005]
Parenterally-administered pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine-deficient newborns and infants; pharmaceuticals for treatment of cysteine deficiencies.

Classification kind code

Mark Details

Serial Number

2032228

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 249 on 5^th Apr 2021	Withdrawn - Madrid Protocol
Submitted for opposition 256 on 5^th Apr 2021	Notification of Possible Opposition Sent
Submitted for opposition 31 on 5^th Jun 2020	Formalized
Submitted for opposition 1 on 5^th Jun 2020	Created
Submitted for opposition 257 on 4^th Jun 2020	Designation Notification - Madrid Protocol
Submitted for opposition 30 on 15^th Jan 2020	Filed
Submitted for opposition 228 on 15^th Jan 2020	International Registration